We are live on ! Find out more
ABPI

Accentia Biopharmaceuticals
ABPI

Delisted

ABPI was delisted on the 3rd of November, 2008.

Back to rankings

2 hedge funds and large institutions have $47 invested in Accentia Biopharmaceuticals in 2013 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

44% less capital invested

Capital invested by funds: $84 → $47 (-$37)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highlander Capital Management
New Jersey
$47 – – –

ABPI Hedge Fund Activity: Q4 2013 in Review

2 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Accentia Biopharmaceuticals (ABPI) for Q4 2013, worth a combined $47 — down 44% from $84 a quarter earlier.

Fund positioning in ABPI was balanced in Q4 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

  • 2 institutional investors held Accentia Biopharmaceuticals (ABPI) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $47 of Accentia Biopharmaceuticals stock for Q4 2013, down 44% quarter-over-quarter.
  • 0 funds opened new Accentia Biopharmaceuticals positions in Q4 2013 and 0 closed out.

Based on aggregated 13F filings for Q4 2013.